Neuromodulation Applications in Femtech
Part of Invention, Investment, and Invigoration (i3): Serving the Patient
Details
- Date
- Thursday, January 21, 2027
- Time
- 2:15 PM – 3:00 PM
- Session type
- Pre-Conference Session
- Schedule
- See this day
About
This full-day pre-conference course will provide a comprehensive overview of the evolving neuromodulation ecosystem, organized around the central theme of serving the patient. Bringing together leaders from academia, industry, and investment, the program will explore the field from technological innovation through commercialization and clinical adoption. Sessions will examine the future of neuromodulation, the funding outlook for emerging startups, and advances in key areas including brain-computer interfaces, neuromodulation for internal organs, and emerging modalities such as ultrasound-based stimulation. Additional discussion will address the critical role of reimbursement and evidence generation in ensuring patient access to new therapies. The course will conclude with a panel featuring senior leaders from major neuromodulation companies sharing perspectives on industry trends and future opportunities. Designed to encourage cross-sector dialogue, the program aims to highlight how scientific, clinical, and business decisions ultimately converge around a common goal: improving outcomes and access for patients.
Presenters
-
JoJo Platt is a recognized leader in the neurotechnology and medtech ecosystems, known for her ability to bridge the gap between research, commercialization, and investment. With years of experience facilitating collaborations between scientists, engineers, and investors, she has played a pivotal role in advancing innovative technologies from concept to market. Her expertise spans neuromodulation, bioelectronic medicine, and early-stage startup strategy, making her an invaluable resource for companies seeking guidance in funding, partnerships, and market positioning. JoJo has worked alongside some of the foremost pioneers in neurotech, advocating for scientific rigor, industry growth, and patient-centric innovation.
Startups looking to navigate the complexities of fundraising, product development, and regulatory landscapes benefit from JoJo’s deep understanding of the neurotech ecosystem. Her extensive network includes venture capitalists, angel investors, and key opinion leaders who help shape the future of healthcare innovation. As a frequent speaker and panel moderator at global conferences, she brings fresh insights into how emerging technologies can successfully transition from academic research to real-world impact. Whether it’s developing commercialization strategies, refining investor pitches, or fostering meaningful collaborations, JoJo’s strategic acumen makes her a trusted advisor for entrepreneurs looking to transform bold ideas into tangible solutions.